💊 Medication Severity Assessment & Classification Analysis
📈 Medication Classification Visualizations
Severity Flag Distribution: Distribution of medications by monitoring complexity. Higher severity levels (orange/red) require more intensive clinical oversight.
Severity Distribution: HTN vs Non-HTN Medications: Comparison of severity levels between HTN and non-HTN medications.
Single vs Combination Medications: Proportion of single-agent versus combination medications.
📋 Severity Level Breakdown
| Severity Level | Description | Count | Percentage | Clinical Rationale |
|---|---|---|---|---|
| Level 0 | No Monitoring Required | 21 | 34.4% | Minimal monitoring requirements, well-established safety profiles |
| Level 1 | Low Complexity/Standard Monitoring | 9 | 14.8% | Standard monitoring protocols, first-line therapies with routine follow-up |
| Level 2 | Medium Complexity/Enhanced Monitoring | 18 | 29.5% | Enhanced monitoring for side effects, drug interactions, or dose titration |
| Level 3 | High Complexity/Intensive Monitoring | 13 | 21.3% | Intensive monitoring required, reserved for complex/refractory cases |
🚨 High-Risk Medications (Severity Level 3)
High-Risk Medications by Category:
ARB:
- Candesartan - HTN-related
- Valsartan - HTN-related
ARB_Combo:
- Sacubitril-Valsartan - HTN-related
BetaBlocker:
- Carvedilol - HTN-related
- Labetalol - HTN-related
CAA:
- Clonidine - HTN-related
- Methyldopa - HTN-related
DirectVasodilator:
- Hydralazine - HTN-related
- Minoxidil - HTN-related
Diuretic:
- Spironolactone - HTN-related
- Bumetanide - HTN-related
HCN_Channel_Blocker:
- Ivabradine - Non-HTN
Nitrate:
- Isosorbide - Non-HTN
🏥 Medication Type Analysis
BetaBlocker (HTN-Related)
Count: 7 medications | Severity Range: 2-3 | Average Severity: 2.3
Examples: Atenolol, Bisoprolol, Carvedilol
Diuretic (HTN-Related)
Count: 6 medications | Severity Range: 1-3 | Average Severity: 2.0
Examples: Chlorthalidone, Furosemide, Hydrochlorothiazide
ARB (HTN-Related)
Count: 5 medications | Severity Range: 1-3 | Average Severity: 1.8
Examples: Candesartan, Losartan, Olmesartan
Statin (Non-HTN)
Count: 5 medications | Severity Range: 0-0 | Average Severity: 0.0
Examples: Atorvastatin, Lovastatin, Pravastatin
CCB (HTN-Related)
Count: 4 medications | Severity Range: 1-2 | Average Severity: 1.5
Examples: Amlodipine, Diltiazem, Nifedipine
Bile_Acid_Sequestrant (Non-HTN)
Count: 3 medications | Severity Range: 0-0 | Average Severity: 0.0
Examples: Cholestyramine, Colesevelam, Colestipol
ACE (HTN-Related)
Count: 2 medications | Severity Range: 1-1 | Average Severity: 1.0
Examples: Enalapril, Lisinopril
Omega3 (Non-HTN)
Count: 2 medications | Severity Range: 0-0 | Average Severity: 0.0
Examples: Icosapent, Omega-3-Acid
DirectVasodilator (HTN-Related)
Count: 2 medications | Severity Range: 3-3 | Average Severity: 3.0
Examples: Hydralazine, Minoxidil
ACE_Combo (HTN-Related)
Count: 2 medications | Severity Range: 2-2 | Average Severity: 2.0
Examples: Benazepril-Hydrochlorothiazide, Lisinopril-Hydrochlorothiazide
📝 Clinical Implementation Guidelines
🎯 Key Recommendations:
- Risk Stratification: Use severity flags to prioritize patients for clinical monitoring intensity and resource allocation
- Care Coordination: Patients on Severity Level 3 medications require specialized clinical oversight and frequent monitoring protocols
📊 Monitoring Framework:
- Level 0-1: Standard care protocols with routine follow-up
- Level 2: Enhanced monitoring with more frequent assessments
- Level 3: Intensive monitoring with specialized clinical expertise required
Report Generated: Medication Severity Assessment & Classification Analysis
Clinical Decision Support Tool for Medication Risk Stratification